IFI-C · Eucalyptol
Specimen SS-F-CLB-290 // COOL BURN · IFI-C
Eucalyptol II-AG-B
Eucalyptus globulus
Eucalyptus
Tier IIEucalyptol
Target Trait
1.9×
fold-change
1,8-cineole accumulation fold-change
Technical Specifications
SKU
SS-F-CLB-290
Genomic Edits
5
GC Content
47.8%
Construct Length
3,292 bp
Promoter System
Tissue-specific 2A11
Expression System
Agrobacterium-mediated T-DNA
Host Strain
EHA105
Receptor Target
TRPM8
IFI Score
190
Pathway Edits
- TPS-cin (1,8-cineole terpene synthase) codon-optimized overexpression cassette
- GPPS2 (geranyl pyrophosphate synthase 2) upregulation for monoterpene precursor flux
- CYP76F (cytochrome P450 76F subfamily) suppression to reduce competing hydroxylation
- MCT (methylerythritol phosphate cytidylyltransferase) MEP pathway amplification
Key Interventions
1,8-cineole overproduction via TPS-cin/GPPS2 co-upregulation in Eucalyptus globulusTRPM8 weak-agonist/TRPA1-antagonist dual mechanism via eucalyptol elevationCYP76F suppression to redirect flux toward 1,8-cineole rather than competing oxygenates
IFI Subscale Profile
IFI Profile
IFI-S—
IFI-U—
IFI-B—
IFI-K—
IFI-C190
IFI-P—
IFI-A—
IFI-F—
Use Case
Eucalyptus flavor ingredient development, menthol-free cooling formulation, oral care product enhancement, and respiratory wellness product applications.
License
$749 · Tier II License
Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.
Already purchased?